logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Ph-positive ALL: chemotherapy-free first-line treatment proves highly successful

Findings from the Italian GIMEMA LAL2116 D-ALBA trial.